Page last updated: 2024-11-05

n-hydroxyurethane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-hydroxyurethane: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11510
CHEMBL ID153081
SCHEMBL ID36772
SCHEMBL ID11678696
MeSH IDM0057471

Synonyms (53)

Synonym
carbamic acid, hydroxy-, ethyl ester
ethyl-n-hydroxycarbamate
ethyl hydroxycarbamate
ethylester kyseliny n-hydroxykarbaminove [czech]
n-hydroxyethyl carbamate
hydroxyurethan
brn 1747529
einecs 209-648-0
ccris 342
ai3-52582
n-hydroxyurethan
589-41-3
sq 16819
hydroxycarbamic acid ethyl ester
nsc-83629
hydroxyurethane
NHU ,
nsc-71045
n-carbethoxyhydroxylamine
nsc71045
wln: qmvo2
n-hydroxy ethyl carbamate
ethyl n-hydroxycarbamate
n-hydroxyurethane
nsc83629
CHEMBL153081 ,
bdbm50121952
vgeweghhywgxgg-uhfffaoysa-
inchi=1/c3h7no3/c1-2-7-3(5)4-6/h6h,2h2,1h3,(h,4,5)
H0618
A832081
FT-0670211
4-03-00-00168 (beilstein handbook reference)
unii-qwi3c4asi7
qwi3c4asi7 ,
ethylester kyseliny n-hydroxykarbaminove
AKOS015856775
n-carboethoxyhydroxylamine
ethylhydroxycarbamate
n-ethoxycarbonylhydroxylamine
SCHEMBL36772
carbamic acid, n-hydroxy-, ethyl ester
ethyl hydroxycarbamate #
SCHEMBL11678696
DTXSID20207635
mfcd00002108
AS-40148
sq-16819
ccris-342
CS-0235105
EN300-152827
n-carbethoxyhydroxylamine, ethyl n-hydroxycarbamate, hydroxycarbamic acid ethyl ester
SY051112

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Other metabolites which have been detected in urine of animals dosed with urethane and N-hydroxyurethane are ethylmercapturic acid, ethylmercapturic acid sulphoxide and N-acetyl-S-carbethoxycysteine."( THE MATABOLISM OF URETHANE AND RELATED COMPOUNDS.
BOYLAND, E; NERY, R, 1965
)
0.47
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (17)

Processvia Protein(s)Taxonomy
proteolysisStromelysin-1Homo sapiens (human)
extracellular matrix disassemblyStromelysin-1Homo sapiens (human)
protein catabolic processStromelysin-1Homo sapiens (human)
regulation of cell migrationStromelysin-1Homo sapiens (human)
collagen catabolic processStromelysin-1Homo sapiens (human)
positive regulation of protein-containing complex assemblyStromelysin-1Homo sapiens (human)
cellular response to reactive oxygen speciesStromelysin-1Homo sapiens (human)
innate immune responseStromelysin-1Homo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionStromelysin-1Homo sapiens (human)
cellular response to lipopolysaccharideStromelysin-1Homo sapiens (human)
cellular response to amino acid stimulusStromelysin-1Homo sapiens (human)
cellular response to UV-AStromelysin-1Homo sapiens (human)
cellular response to nitric oxideStromelysin-1Homo sapiens (human)
regulation of neuroinflammatory responseStromelysin-1Homo sapiens (human)
response to amyloid-betaStromelysin-1Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processStromelysin-1Homo sapiens (human)
extracellular matrix organizationStromelysin-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
endopeptidase activityStromelysin-1Homo sapiens (human)
metalloendopeptidase activityStromelysin-1Homo sapiens (human)
serine-type endopeptidase activityStromelysin-1Homo sapiens (human)
protein bindingStromelysin-1Homo sapiens (human)
peptidase activityStromelysin-1Homo sapiens (human)
metallopeptidase activityStromelysin-1Homo sapiens (human)
zinc ion bindingStromelysin-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
extracellular regionStromelysin-1Homo sapiens (human)
nucleusStromelysin-1Homo sapiens (human)
mitochondrionStromelysin-1Homo sapiens (human)
cytosolStromelysin-1Homo sapiens (human)
extracellular matrixStromelysin-1Homo sapiens (human)
extracellular spaceStromelysin-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID208331Binding to stromelysin (MMP-3) in place of acetohydroxamic acid.2002Journal of medicinal chemistry, Dec-19, Volume: 45, Issue:26
NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (66.67)18.7374
1990's0 (0.00)18.2507
2000's3 (20.00)29.6817
2010's2 (13.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.75 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]